Robert Kramer

Insider Reports History

Entity
Individual
Location
2273 Research Blvd, Suite 400, Rockville, MD
Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Kramer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Emergent BioSolutions Inc. President and CEO, Director Common Stock 506K $921K $1.82 Jun 9, 2023 Direct
Emergent BioSolutions Inc. President and CEO, Director Employee Stock Option (Right to buy) 535K Jun 9, 2023 Direct
Emergent BioSolutions Inc. President and CEO, Director Employee Stock Options (Right to Buy) 258K Mar 2, 2023 Direct

Insider Reports Filed by Robert Kramer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EBS Emergent BioSolutions Inc. Jun 9, 2023 3 $0 4 Jun 13, 2023 President and CEO, Director
EBS Emergent BioSolutions Inc. Mar 2, 2023 3 $0 4 Mar 6, 2023 President and CEO, Director
EBS Emergent BioSolutions Inc. Feb 28, 2023 1 -$39.9K 4 Mar 2, 2023 President and CEO, Director
EBS Emergent BioSolutions Inc. Feb 23, 2023 2 -$42.2K 4 Feb 27, 2023 President and CEO, Director
EBS Emergent BioSolutions Inc. Feb 8, 2023 2 -$65.5K 4 Feb 10, 2023 President and CEO, Director
EBS Emergent BioSolutions Inc. Feb 28, 2022 4 $5.53M 4 Mar 2, 2022 President and CEO, Director
EBS Emergent BioSolutions Inc. Feb 23, 2022 2 -$146K 4 Feb 25, 2022 President and CEO, Director
EBS Emergent BioSolutions Inc. Feb 22, 2022 2 -$194K 4 Feb 24, 2022 President and CEO, Director
EBS Emergent BioSolutions Inc. May 8, 2021 1 -$5.79K 4 May 11, 2021 President and CEO, Director